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disease: testing insulin resistance and sleep
disordered breathing mechanisms
Matthew T Haren1,2,3*, Gary Misan3, Tracey-Jayne Paterson2,3, Richard E Ruffin4, Janet F Grant5,
Jonathan D Buckley6, Peter RC Howe6, Jonathan Newbury2, Anne W Taylor5 and Robyn A McDermott1Abstract
Background: This study examined associations of abdominal adiposity with lung function, asthma symptoms and
current doctor-diagnosed asthma and mediation by insulin resistance (IR) and sleep disordered breathing (SDB).
Methods: A random sample of 2500 households was drawn from the community of Whyalla, South Australia (The
Whyalla Intergenerational Study of Health, WISH February 2008 - July 2009). Seven-hundred twenty-two randomly
selected adults (≥18 years) completed clinical protocols (32.2% response rate). Lung function was measured by
spirometry. Post-bronchodilator FEV1/FVC was used to measure airway obstruction and reversibility of FEV1 was
calculated. Current asthma was defined by self-reported doctor-diagnosis and evidence of currently active asthma.
Symptom scores for asthma (CASS) and SDB were calculated. Intra-abdominal fat (IAF) was estimated using
dual-energy x-ray absorptiometry (DXA). IR was calculated from fasting glucose and insulin concentrations.
Results: The prevalence of current doctor-diagnosed asthma was 19.9% (95% CI 16.7 – 23.5%). The ratio of
observed to expected cases given the age and sex distribution of the population was 2.4 (95%CI 2.1, 2.9). IAF was
not associated with current doctor-diagnosed asthma, FEV1/FVC or FEV1 reversibility in men or women but was
positively associated with CASS independent of IR and SDB in women. A 1% increase in IAF was associated with
decreases of 12 mL and 20 mL in FEV1 and FVC respectively in men, and 4 mL and 7 mL respectively in women.
SDB mediated 12% and 26% of these associations respectively in men but had minimal effects in women.
Conclusions: In this population with an excess of doctor-diagnosed asthma, IAF was not a major factor in airway
obstruction or doctor-diagnosed asthma, although women with higher IAF perceived more severe asthma
symptoms which did not correlate with lower FEV1. Higher IAF was significantly associated with lower FEV1 and FVC
and in men SDB mechanisms may contribute up to one quarter of this association.
Keywords: Airway obstruction, Forced Expiratory Volume, Forced Vital Capacity, Asthma, Abdominal adiposity,
Sleep disordered breathingBackground
Obesity, as defined by body mass index (BMI) has been
shown to be associated with a 2.5-fold increase in the risk
of current doctor-diagnosed asthma in women but not in
men [1] and the association appears to be specific to non-
atopic asthma [2,3]. Raviv et al. [4] showed that obesity* Correspondence: Matt.Haren@unisa.edu.au
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reproduction in any medium, provided the orwas associated with asthma symptoms only in the least
obstructed tertile, as measured by the ratio of FEV1
(forced expired volume in one second) to FVC (forced
vital capacity). Together, these findings suggest that obes-
ity may produce a mild obstructive airway phenotype dis-
tinct from that mediated by type 2 T-helper (Th2) cell
inflammatory pathways [5]. Moreover, in one of the first
studies to explore the associations between spirometric
lung function and adiposity using DXA-measured fat
mass, Sutherland and colleagues demonstrated correla-
tions of total, trunk and abdominal fat masses with FVCtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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small convenience sample. This study was unable to adjust
for potential confounders or investigate potential mechan-
isms and thus could not provide accurate estimates of the
direct and indirect associations between adiposity and
lung function and did not include a measurement of air-
way obstruction [6].
Proposed mechanisms for an obesity-induced obstruct-
ive airway phenotype include, amongst others, insulin re-
sistance (IR) [7,8] and sleep disordered breathing (SDB)
[5]. The mechanisms by which SDB could increase asthma
severity are not known, but potentially involve increased
vagal tone, leading to bronchoconstriction; upper airway
inflammation, leading lower airway inflammation; and
perturbations in central control of bronchomotor tone [5].
The authors have previously reported strong positive asso-
ciations between the frequency of SDB symptoms and ex-
pression of fat mass/hyperinsulinaemia, glycaemia and
lipid/lean mass phenotypes in non-diabetics in the popula-
tion under study which has a prevalence of abdominal
obesity of 50% [9]. Thus, this population appears suited to
examine this hypothesis.
Research context
The industrial, outer regional city of Whyalla in South
Australia has a complex mix of social and physical envir-
onmental exposures which may relate to excess asthma
risk. Public perceptions about the causes of respiratory
ill-health in this community may be dominated by the
tangible evidence of the once visible ‘red dust’ from the
process of pelletising iron ore for Steelmaking and
uncovered exporting of iron ore in the city [10]. An eco-
logical study, using administrative data from 1977 to
2005 suggested that asthma, chronic lung disease, and
lung cancer were in excess in Whyalla, but that the
prevalence of smoking was similar in Whyalla when
compared with other ‘dusty’ regional South Australian
cities [11]. This suggests that local environmental or
population factors might be contributing to the excess of
respiratory disorders in Whyalla.
This study aimed to test the hypotheses that abdom-
inal adiposity, which has been shown to be at high
prevalence in this community, is associated with poorer
lung function, increased severity of asthma symptoms
and a higher prevalence of current doctor-diagnosed
asthma through mechanisms involving IR or SDB.
Methods
Sampling and recruitment
The Whyalla Intergenerational Study of Health (WISH)
cohort was established between February 2008 and July
2009. Whyalla households (n= 2500) were randomly
selected from the residential housing database of the State
Planning Authority. The strength of this sampling framewas the completeness, however approach and recruitment
was a complex multi-stage process due to limited contact
information in the databases (residential address only).
This novel sampling frame was used instead of telephone
listings (Electronic White PagesW (EWPs)) due to a high
proportion of households without landline telephone con-
nections, which is more common in rural than metropol-
itan South Australia [12]. Invitations to participate,
addressed to “The Householder”, were mailed to randomly
selected households, co-ordinated with a community-wide
media campaign informed by a Community Advisory
Group. Householders were invited to register online or by
telephone, providing their telephone number and basic
demographic information. One-hundred seventy-eight
(7%) households responded to this approach. The second
stage successfully matched 1183 of the randomly selected
household addresses in the sample to names and tele-
phone numbers in the EWPs. Thirdly, remaining un-
matched randomly selected households were approached
by door-knocking; a minimum of two attempts to contact
were made and calling cards were left.
Once telephone numbers were obtained, Computer
Assisted Telephone Interviewing (CATI) technology was
used to recruit the adult (≥18 years) in each household
who last had their birthday [13], and to collect demo-
graphic, health and risk factor data and schedule clinical
assessments. Interviews were conducted by trained inter-
viewers under established protocols [13,14]. Participants
provided written informed consent at the time of clinical
assessment. Protocols and procedures were approved by
the Human Research Ethics Committee of The Univer-
sity of South Australia and the Aboriginal Health Re-
search Ethics Committee of South Australia.
Major outcome measures
Spirometry, including bronchodilator reversibility was
performed in accordance with American Thoracic Soci-
ety guidelines [15] and manufacturer’s recommendations
using portable ultrasonic sensor spirometers (ndd Easy-
One™) interfaced with EasyWare 2008 (ndd Medizintech
AG, Zurich Switzerland) on laptop computers. This de-
vice has been demonstrated to maintain good stability
during everyday use in Australian general practice and
does not require daily calibration [16]. Quality control
was maintained by achieving a minimum of three trials
with volumes within 3% and achieving the manufac-
turers recommended minimum system quality control
grade. The primary spirometric outcome was airway ob-
struction measured by post-bronchodilator FEV1/FVC.
The degree of reversibility in the FEV1 was calculated as:
100 x FEV1 (post-bronchodilator) – FEV1,(baseline)/
FEV1 (baseline). Secondary outcomes were post-
bronchodilator FEV1; FVC; peak expiratory flow (PEF);
and the average expired flow over the middle half of the
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referenced to South Australian-derived prediction equa-
tions of Gore et al. [17] and expressed as the percentage
of predicted value (PPV).
Self-reported ‘ever doctor-diagnosed asthma’ was
defined as answering yes to either: (1) Have you ever
been told by a doctor that you have any of the following
conditions? (option 2 =Asthma); or (2) have you ever
been told by a doctor that you have asthma? ‘Current
doctor-diagnosed asthma’ was defined as ‘ever doctor-
diagnosed asthma’ plus evidence of currently active
asthma defined by positive responses to any of the fol-
lowing questions: (1) During the past 12 months, did
you have any symptoms of asthma? (2) During the past
12 months, did you take asthma medication that was
prescribed or given to you by a doctor? (3) Do you still
have asthma? The frequency of three asthma symptoms
(wheeze, shortness of breath and cough; scored as never
(0), occasionally (1), most days/every day (2)) and the
amount of phlegm produced during cough (none (0), a
little (1), several tablespoons/day or more (2)) over the
past three months [18], were summed to produce a
comprehensive asthma symptom score (CASS) ranging
from zero indicating no asthma symptoms to eight indi-
cating the highly frequent presence of all four
symptoms.
Independent variables
Body composition was assessed using dual-energy x-ray
absorptiometry (DXA, Lunar Prodigy, GE Medical Sys-
tems, Madison WI) with the manufacturer’s software
(enCORE 2003 version 7.52). Scans were performed
according to the manufacturer’s protocols with partici-
pants supine. Total body fat mass (g) was determined
automatically from the manufacturer’s software. Total
intra-abdominal fat (IAF) mass was estimated by defin-
ing a region of interest in the abdomen by drawing
quadrilateral box with the base touching the top of the
iliac crest, the upper margins touching the most inferior
aspect of the ribs and the lateral borders extending to
the inner border of the rib cage. IAF percentage was
estimated as fat mass / (fat mass + lean mass + bone
mineral content) * 100.
Fasting, morning venous blood samples were collected
(approximately 40 mL) and assayed by a National Asso-
ciation of Testing Authorities accredited laboratory.
Fasting plasma glucose concentrations were measured
using a Chemistry analyser system (Olympus AU5400,
Olympus Optical C Ltd, Japan) with inter-assay CVs of
2.41% at 3.41 mmol/L and 2.21% at 19.72 mmol/L. Fast-
ing serum insulin concentrations were measured in
serum collected, separated and frozen at −80°C within
two hours of collection. Radioimmunoassay was per-
formed on an Abbott Architect immunoassay analyser(Abbott Park, IL USA) with inter-assay CVs of 7.81% at
8.44 mU/L, 5.87% at 57.44 mU/L and 8.53% at
97.90 mU/L. IR was estimated from these two concen-
trations using the Homeostasis Model Assessment
(HOMA2) Microsoft Excel calculator from the Univer-
sity of Oxford Diabetes Trial Unit (http://www.dtu.ox.ac.
uk/homacalculator/index.php) which uses the equations
of Levy and colleagues [19]. A SDB symptom score
(range 0–12) was computed as the sum of symptom fre-
quency from zero (never) to four (>4 times per week)
for three symptoms: snorting or gasping; loud snoring;
and breathing cessation, choking or struggling for breath
during sleep [20].
Covariates
Height was determined to within one millimetre using a
wall stadiometer (Surgical and Medical Products No.
26SM, Mentone Education Supplies, Melbourne, Austra-
lia), body mass was measured to the nearest 100 g with an
electronic scale (Tanita BF-681). Smoking status was
defined as ‘never smoker’, ‘past smoker’ and ‘current
smoker’. Gross annual household income was collected in
approximate 20,000 Australian Dollar (AUD) increments
and reduced to three categories of 40,000 AUD incre-
ments for analysis. The number of people residing in the
household was categorised as one, two, three, four, and
five or more. Medication inventory was performed during
clinical assessment and participants were asked if they had
taken bronchodilators or any other respiratory medication
in the previous 24 hours. Doctor-diagnosis of Obstructive
Sleep Apnoea Syndrome (OSAS) and management of
OSAS with Continuous Positive Airway Pressure (CPAP)
therapy was determined by questionnaire.
Statistical analysis
Data analysis was performed using Stata 11 for Windows
(StataCorp, College Station TX USA). For prevalence
estimates, data were weighted to the age and sex distri-
bution of the Estimated Residential Population of Why-
alla in 2007 [21] and the likelihood of being recruited
into the study, as per the equation: weight = hhld_adult*
(bnh/lnh)*(ln/bn); where hhld_adult is the number of
people aged 18 and over (adults) residing in the house-
hold; bnh is the adult population size of Whyalla by sex
and age-group; bn is the total adult population of Why-
alla; lnh is the adult sample size of WISH by sex and
age-group; and ln is the total adult sample size of the
WISH cohort. To calculate the Australian standardised
prevalence ratio (SPR) for current doctor diagnosed
asthma in Whyalla, the stratum-specific prevalence esti-
mates from the national standard population data [22]
were used to calculate the expected number of cases in
the study population (WISH). Expected cases were
summed across strata, and compared with the number
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observed to expected cases. The same method was used
to estimate the SPR’s for current and past smoking using
2007–2008 Australian NHS data as the standard
population.
Ordinary least squares regression was used to model
the associations of IAF with: spirometric outcomes and
log-CASS. Prevalence ratios (PR) for the association of
IAF with current doctor diagnosed asthma were esti-
mated using Generalised Linear Models with Poisson
distribution, log-link function and robust estimation of
confidence intervals as suggested by Wolkewitz et al.
2007 [23]. Formal mediation tests were conducted in
Stata 11 using -sgmediation-, which uses bootstrap ana-
lyses to estimate the indirect effect of the independent
variable on the dependent variable through the mediator
variable, overcoming the assumption of a normal sam-
pling distribution required for use of the classical Sobel
test. Bootstrap analysis involves drawing a large number
of samples, in this case 5000 (with replacement), from
the data set, computing the indirect effect for each sam-
ple, and then generating an average indirect effect across
all samples. Regression paths and criteria for mediation
followed those outlined by Baron and Kenny [24] and
summarised in Figure 1.
Results
Overall, 51% of eligible households participated in the
CATI and 32.2% participated in the clinical study
(Figure 2).
The estimated population prevalence of current doctor-
diagnosed asthma was 19.9% [95% CI 16.7 – 23.5%] which
was 2.4 times higher than Australian national prevalence
estimates after age- and sex-standardisation [95%CI for
the SPR 2.1 – 2.9]. The prevalence of both current (23%
[95% CI 19.6 – 26.7%]; SPR 1.11 [95% CI 0.95 - 1.29]) and
past smoking (28.6% [95% CI 25.1 – 32.4%]; SPR 0.96
[95% CI 0.83 - 1.10]) in Whyalla were similar to those of
Australia overall.Figure 1 Regression Paths in Mediation Analysis. The mediation mode
path c association; (2) significant path a association; (3) significant path b aOf the 726 adults who completed comprehensive ques-
tionnaires, 236 men and 348 women (n= 562, 78%) com-
pleted baseline and post-bronchodilator spirometric
manoeuvres of acceptable quality. In total, 98 participants
did not complete spirometry tests for various reasons:
opted out (n= 29); terminated spirometry protocols early
(n= 66); excluded on the basis of illness, injury or doctor’s
advice (n= 3). Sixty-six participants completed spirometry,
but breathing manoeuvres were of unacceptable quality to
provide valid and reliable data (n= 60) or technical mal-
functions were experienced (n= 6).
Post-bronchodilator FEV1/FVC, FEV1, PEF and FEF25%-75%
were all lower and there was a non-significant trend to-
wards higher FEV1 reversibility in current doctor-diagnosed
asthmatics when compared with non-asthmatics. CASS
was higher in current doctor-diagnosed asthmatics when
compared with non-asthmatics but it did not differ by spir-
ometry completion or quality grade in either group
(Table 1). Neither IR nor SDB symptom scores were higher
in the current doctor-diagnosed asthmatics when compared
with non-asthmatics, but within the doctor-diagnosed
group, IR was higher in those who did not attempt or
complete an acceptable spirometry test (Table 1). A
complete respiratory, metabolic and socio-demographic de-
scription of the study sample by asthma diagnosis is pre-
sented in Additional file 1.
Obstructive sleep apnoea syndrome (OSAS) had been
doctor-diagnosed in 42 participants (5.9%) and 20 of
these used CPAP to manage the condition. CPAP use
was associated with a lower log CASS (1.18 ± 0.56 v
1.52 ± 0.40, p = 0.04) but non-significant differences in
current doctor diagnosed asthma prevalence, IAF, IR,
SDB symptom score, post FEV1/FVC and reversibility of
FEV1 (data not shown).
Table 2 shows the covariate-adjusted associations of IAF
with current doctor-diagnosed asthma, CASS, spirometric
outcomes, IR and SDB symptom frequency in men and
women who completed acceptable spirometry tests. IAF
was not associated with current doctor-diagnosed asthma,l of Baron & Kenny, 1986 [24]. Criteria for mediation are: (1) significant
ssociation with a reduction in the path c coefficient (c`)
Figure 2 Flowchart of participation in the Whyalla Intergenerational Study of Health (WISH, 2008–2009).
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Table 1 Respiratory, metabolic and socio-demographic characteristics, The Whyalla Intergenerational Study of Health
(WISH, 2008–2009)
Current Doctor-Diagnosed Asthma Asthma x spirometry quality
No (n = 575) Yes (n = 151) F(df) or Chi2(df) P F(df) or Chi2(df) P
Completion/ No test 77 21
acceptability of spirometry Unacceptable 51 15
Acceptable 447 115
Outcomes, asthma symptoms
CASS, range 0-8 No test 3.62 (3.26, 3.99) 5.33 (4.64, 6.27) F(5,711) = 19.26 <0.001 F(2,711) = 1.16 0.32
Unacceptable 3.28 (2.83, 3.72) 5.23 (4.35, 6.11)
Acceptable 3.28 (3.13, 3.43) 4.56 (4.26, 4.86)
log CASS No test 1.16 (1.05, 1.27) 1.63 (1.41, 1.84) F(5,711) = 14.33 <0.001 F(2,711) = 0.55 0.58
Unacceptable 1.09 (0.95, 1.22) 1.54 (1.27, 1.82)
Acceptable 1.07 (1.03, 1.12) 1.42 (1.33, 1.51)
Outcomes, spirometry
(acceptable tests only)
FEV1 reversibility, L 0.11 (0.09, 0.12) 0.12 (0.09, 0.14) F(1, 538) = 0.22 0.64
FEV1 reversibility,% 3.88 (3.27, 4.49) 5.03 (3.83, 6.24) F(1, 538) = 2.80 0.10
post FEV1, L 3.01 (2.93, 3.10) 2.76 (2.60, 2.92) F(1, 538) = 7.62 <0.01
post FVC, L 3.80 (3.70, 3.90) 3.64 (3.44, 3.83) F(1, 523) = 2.02 0.16
post FEV1/FVC,% 79.46 (78.73, 80.19) 76.14 (74.70, 77.57) F(1, 523) = 16.34 <0.001
post PEF, L/s 7.83 (7.62, 8.03) 7.23 (6.83, 7.63) F(1, 538) = 6.80 <0.01
post FEF25%-75%, L/s 3.06 (2.94, 3.17) 2.55 (2.32, 2.78) F(1, 538) = 15.16 <0.001
FEV1, ppv† 90.34 (88.79, 91.88) 84.20 (81.16, 87.24) F(1, 538) = 12.46 <0.001
FVC, ppv† 93.90 (92.44, 95.35) 91.70 (88.81, 94.60) F(1, 523) = 1.76 0.19
FEV1/FVC, ppv† 96.66 (95.81, 97.50) 91.03 (89.35, 92.70) F(1, 523) = 34.55 <0.001
PEF, ppv† 97.24 (95.50, 98.98) 92.44 (89.02, 95.85) F(1, 538) = 6.03 0.02
FEF25%-75%, ppv† 84.55 (81.90, 87.20) 71.28 (66.07, 76.49) F(1, 538) = 19.79 <0.001
Independent variables
Intra-abdominal fat,% No test 39.58 (37.26, 41.90) 39.44 (34.92, 43.96) F(5,692) = 1.16 0.33 F(2,692) = 1.71 0.18
Unacceptable 38.81 (35.92, 41.70) 33.06 (27.66, 38.47)
Acceptable 39.55 (38.57, 40.52) 39.91 (37.99, 41.83)
Mediator variables
HOMA2-IR No test 1.35 (1.09, 1.66) 2.01 (1.52, 2.52) F(5,703) = 1.51 0.19 F(2,703) = 3.18 0.04
Unacceptable 1.39 (1.06, 1.71) 1.71 (1.09, 2.34)
Acceptable 1.40 (1.30, 1.59) 1.32 (1.11, 1.54)
SDB symptom score, range 0-12 No test 1.18 (0.63, 1.73) 1.87 (0.75, 2.98) F(5,594) = 1.74 0.12 F(2,594) = 0.07 0.93
Unacceptable 1.54 (0.83, 2.25) 2.09 (0.79, 3.40)
Acceptable 0.96 (0.74, 1.18) 1.39 (0.93, 1.85)
A description of the outcome, independent and mediator variables, and covariates by current doctor-diagnosed asthma and spirometry completion and quality,
The Whyalla Intergenerational Study of Health (WISH, 2008–2009).
Determination of ‘unacceptable test’ was based on either baseline and post-bronchodilator EasyOne™ system quality control (QC) grade of D or lower, or non-
reproducible trials exceeding 3% variability. The analytical sample satisfied a QC grade of C or higher and reproducible trials within 3% variability. †Percentage of
Predicted Value (PPV) was based on equations of Gore et al. (1995) [17].
Haren et al. BMC Pulmonary Medicine 2012, 12:31 Page 6 of 11
http://www.biomedcentral.com/1471-2466/12/31
Table 2 Associations of intra-abdominal fat percentage with lung function and asthma outcomes, and hypothesised
mediators (sleep disordered breathing score and insulin resistance) in men and women, The Whyalla Intergenerational
Study of Health (WISH, 2008–2009)
Men Women
Coef. (bootstrap 95%CI) P R-squared Coef. (bootstrap 95%CI) P R-squared
Current doctor-diagnosed asthma 1.002 (0.975, 1.029) 0.913 1.004 (0.983, 1.027) 0.686
Obs 214 320
log CASS 0.006 (0.000, 0.012) 0.045 0.148 0.009 (0.002, 0.016) 0.011 0.123
Obs 213 317
rev FEV1 0.045 (−0.045, 0.135) 0.328 0.077 0.005 (−0.063, 0.073) 0.892 0.026
Obs 212 313
post FEV1/FVC
L/L 0.065 (−0.028, 0.158) 0.172 0.363 0.056 (−0.002, 0.113) 0.056 0.321
PPV (Gore et al. [17]) 0.090 (−0.029, 0.209) 0.138 0.229 0.066 (−0.033, 0.165) 0.194 0.129
Obs 210 300
SDB 0.055 (0.017, 0.094) 0.005 0.129 0.024 (0.002, 0.047) 0.034 0.083
Obs 178 273
HOMA2-IR 0.059 (0.048, 0.071) <0.001 0.272 0.052 (0.038, 0.065) <0.001 0.286
Obs 214 318
Associations of intra-abdominal fat percentage with lung function and asthma outcomes, and hypothesised mediators (sleep disordered breathing score and
insulin resistance) in men and women, The Whyalla Intergenerational Study of Health (WISH, 2008–2009). FEV1, forced expiratory volume in 1 second; FVC, forced
vital capacity; IR, insulin resistance (HOMA2); SDB, sleep-disordered breathing. Covariates included in all models were age, current and past smoking, gross annual
household income and number of household residents. For lung function models height and respiratory medication in the previous 24 hours were included as
covariates.
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men or women. A one percent increase in IAF was asso-
ciated with a significant >1 unit increase in CASS in both
men and women (0.006 and 0.009 respectively on the log
scale) although the association in men was of borderline
significance and was not robust to repeated bootstrap ana-
lysis. The associations of CASS with both FEV1/FVC and
FEV1 were different between men and women. For every
log-unit increase in CASS FEV1/FVC declined by 4%
(p <0.001) and FEV1 by 295 mL in men (p= 0.007) but
there were no associations in women.
A one percent increase in IAF was associated with a
12 ml and 20 mL decrease in FEV1 and FVC respectively
in men and a 4 ml and 7 mL decrease respectively in
women. This corresponded to reductions in the percent-
age of predicted value for FEV1 of 34% in men and 16%
in women; and for FVC of 46% in men and 24% in
women. IAF was positively associated with IR and SDB
symptom frequency in both men and women, although
the significance of the association at p <0.05 between
SDB and IAF in women was not robust to repeated
bootstrap analysis.
The significant associations of IAF with CASS, FEV1
and FVC were tested for mediation by IR and SDB
symptom frequency in men and women. After adjust-
ment for IAF, IR was not associated with any of the
three outcomes in men or women (path b, data notshown) and thus did not meet the necessary criteria for
mediation. In men, after adjustment for IAF, SDB fre-
quency was significantly associated with FEV1 and FVC
(path b) and mediated between 12% and 26% of the
associations with IAF (Table 3). The small total ‘effec-
t’(association) between IAF and CASS in men did not
reach significance during mediation analysis and thus
the 65% mediation of that association is of little signifi-
cance. In women, associations between the SDB and IAF
were weak and of borderline significance corresponding
to relatively minor indirect effects.Discussion
In this population there was little evidence to support
the existence of an obesity-induced obstructive airway
phenotype. These findings are inconsistent with the pre-
viously documented associations between central obesity
and asthma, particularly mild non-atopic asthma pheno-
types [1-3,25]. This may suggest the dominance of other
asthma-causing agents over obesity in this population.
The only indication of a link between abdominal adipos-
ity and asthma was the association between greater IAF
and more frequent asthma symptoms, particularly in
women where there was no relation to measured airway
obstruction. Thus, this association may be partly
explained by greater perceived exertion from daily
Table 3 Mediation by sleep-disordered breathing symptom frequency of associations of intra-abdominal fat with comprehensive asthma symptom score, FEV1
and FVC expressed as Litres and ‘percentage of predicted values’ (PPV) in men and women, The Whyalla Intergenerational Study of Health (WISH, 2008–2009)
Path a Path b Total effect (Path c) Direct effect (Path c') Bootstrapped %
Dependent variables (dv) mv regressed on IAF dv regressed on mv dv regressed on IAF dv regressed on IAF Indirect Effect Mediated
controlling for IAF controlling for mv
MEN
log CASS, n= 178 0.060 (0.025, 0.094) 0.061 (0.027, 0.095) 0.006 (−0.002, 0.013) 0.002 (−0.006, 0.010) 0.004 (0.001, 0.007) 64.7
post FEV1, n= 178
Litres 0.060 (0.025, 0.094) −0.047 (−0.080, -0.014) −0.012 (−0.019, -0.005) −0.009 (−0.017, -0.002) −0.003 (−0.006, -0.001) 23.4
PPV (Gore et al. [17]) 0.061 (0.026, 0.096) −1.462 (−2.370, -0.555) −0.344 (−0.553, -0.135) −0.255 (−0.466, -0.045) −0.087 (−0.187, -0.026) 25.8
post FVC, n= 176
Litres 0.060 (0.026, 0.095) −0.040 (−0.079, -0.002) −0.020 (−0.029, -0.011) −0.018 (−0.027, -0.009) −0.002 (−0.006, -0.000) 12.1
PPV (Gore et al. [17]) 0.061 (0.026, 0.096) −1.271 (−2.104, -0.439) −0.467 (−0.658, -0.275) −0.389 (−0.583, -0.196) −0.076 (−0.154, -0.025) 16.6
WOMEN
log CASS, n= 271 0.024 (−0.001, 0.049) 0.054 (0.023, 0.085) 0.010 (0.003, 0.016) 0.008 (0.002, 0.015) 0.001 (0.000, 0.003) 13.7
post FEV1, n= 267
Litres 0.021 (−0.004, 0.047) −0.018 (−0.044, 0.009) −0.005 (−0.010, 0.001) −0.004 (−0.010, 0.002) −0.000 (−0.002, 0.000) 8.5
PPV (Gore et al. [17]) 0.021 (−0.004, 0.047) −0.821 (−1.810, 0.167) −0.204 (−0.409, 0.001) −0.186 (−0.392, 0.020) −0.019 (−0.066, 0.001) 8.6
post FVC, n= 254
Litres 0.022 (−0.005, 0.048) −0.013 (−0.044, 0.019) −0.008 (−0.014, -0.001) −0.007 (−0.014, -0.001) −0.000 (−0.002, 0.000) 3.7
PPV (Gore et al. [17]) 0.021 (−0.005, 0.048) −0.587 (−1.551, 0.377) −0.263 (−0.461, -0.064) −0.250 (−0.449, -0.051) −0.013 (−0.065, 0.006) 4.8
Mediation by sleep-disordered breathing symptom frequency of associations of intra-abdominal fat with comprehensive asthma symptom score, FEV1 and FVC expressed as volumes and ‘percentage of predicted
values’ (PPV) in men and women, The Whyalla Intergenerational Study of Health (WISH, 2008–2009).
CASS, comprehensive asthma symptom score; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; PPV, Percentage of Predicted Value. Criteria for mediation are: (1) significant path c association; (2)
significant path a association; (3) significant path b association with a reduction in the path c coefficient (c`). Covariates included in all models were age, current and past smoking, gross annual household income and
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than true airway obstruction.
The contribution of the high prevalence of abdominal
obesity to the relative 2.4 case excess of current doctor-
diagnosed asthma in this community would appear
therefore to be low and instead be dominated by non-
obesity induced phenotypes. Asthma symptoms were
higher and post-bronchodilator lung function was
poorer in those who reported a current doctor-diagnosis
of asthma, but as previously noted asthma symptom
scores were poorly correlated with measured airway ob-
struction in women, who were significantly more likely
than men to report a current doctor-diagnosis of
asthma. Anecdotally, there is high awareness of respira-
tory disease in this city which may contribute to greater
knowledge of respiratory symptoms, higher levels
of help-seeking by those experiencing respiratory symp-
toms (which may be biased towards women) and more
widespread asthma screening and diagnosis by general
practitioners. In terms of other potentially contributing
population factors, the city has a greater than twenty
percent enrichment of blue-collar workers when com-
pared with South Australia and Australia overall [26],
who are largely employed in the steel industry. This may
confer significantly more occupational asthma on the
population over and above the 15% of cases in working
aged adults estimated to be either caused or aggravated
by occupational exposures from previous research [27].
The degree to which occupational exposures, environ-
mental dust exposure or other population factors such
as asthma awareness (population and general practi-
tioners) and vigilance in help-seeking contribute to the
excess of, and gender difference in, current doctor-
diagnosed asthma remains to be determined in this
community which has implications for community inter-
ventions on asthma.
IAF was, however, associated with FEV1 and FVC in
the Whyalla population. Based on age-related rates of
decline in lung volumes from the US National Health
and Nutrition Examination Survey (NHANES) [28] a
five percent increase in IAF (adjusted for IR or SDB
symptom frequency) was equivalent to two years of
age-related decline in the FEV1 (60 ml) and more
than three years of age-related decline in the FVC
(100 ml) of men; the effects were up to three times
smaller in women. These associations, including being
three to four times weaker in women compared with men,
were of similar magnitude to those of other studies
[25,29-31], although the range of adiposity measures used
make cross-study comparisons difficult.
We did not observe the inverse association between IR
and expired lung volumes previously reported in cross-
sectional studies of other populations [32,33]. Prospect-
ive studies have shown that reduced lung function canprecede the development of IR and diabetes [34-39] pos-
sibly through microangiopathy of alveolar capillaries and
pulmonary arterioles [40,41]. Thus it is possible that the
absence of a cross-sectional association between lung
function and IR in this study may be due to healthy-
participant bias. If those with more advanced disease
(reduced lung function) and IR, were less likely to par-
ticipate due to poor health (or having died) than those
with earlier stage reductions in lung function without
IR, then the association between lung function and IR
would be underestimated.
Associations between IAF and SDB symptom fre-
quency were weaker in women than in men and had
negligible mediating effects on FEV1, FVC or CASS. In
men however, SDB symptom frequency mediated be-
tween 12% and 17% of the association of IAF with FVC
and between 23% and 26% of the association with
FEV1. This finding is inconsistent with two small
studies (n ≤20) that suggested six to eight weeks of con-
tinuous positive airway pressure treatment for sleep ap-
noea was not effective in improve spirometric measures of
lung function [42,43] but improved asthma symptoms.
These studies were unlikely to have been powered to de-
tect meaningful changes in these outcomes, but they do
raise caution about interpreting causal directions from
these cross-sectional findings.
There is no universally applied clinical definition of
asthma and case assignment in epidemiological studies
is often defined by self-reported doctor-diagnosis, which
has good sensitivity (91%), specificity (97%) and reason-
able positive predictive value (60%) for indicating preva-
lent disease [44]. The combination of measured lung
function, self-reported asthma symptom frequency and
doctor-diagnosed current asthma as outcomes; and the
specific focus on intra-abdominal fat estimated using
DXA measurements as opposed to most other studies
which have relied on BMI or waist girths as measures of
adiposity are particular strengths of this study. Assess-
ment of SDB was limited to self-reported symptom fre-
quencies which have good sensitivity (85%) but poor
specificity (55%) for identifying men with obstructive
sleep apnoea [20].
In terms of potential selection bias, this cohort was
10% under-represented by state-administered housing
residents which, due to greater odds of current doctor-
diagnosed asthma in lower-income households combined
with greater odds of abdominal obesity and diabetes
in households with gross annual income below 40,000
AUD in this community (unpublished observations),
would theoretically result in an underestimate of the
true abdominal adiposity-current doctor diagnosed asthma
association. However, given the strength of the null
finding it is unlikely that elimination of this potential
bias would shift the association to a degree which would
Haren et al. BMC Pulmonary Medicine 2012, 12:31 Page 10 of 11
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we showed that within the current doctor-diagnosed
asthmatics, IR was higher in those who did not at-
tempt or complete an acceptable spirometry test. As
stated previously, if those asthmatics with more se-
vere IR for which acceptable quality spirometric data
were not available also had poorer lung function, than
those without IR, then the association between lung
function and IR would theoretically be underestimated.
However, Table 1 also reveals evidence that CASS did not
differ by spirometry completion or quality grade in either
current doctor-diagnosed asthmatics or non-asthmatics
which suggests non-completion of successful spirometry
was not dependent on greater obstructive airway symp-
tom severity indicating that this may in fact not be a
source of bias.
Conclusions
In this population with a high prevalence of abdominal
obesity and an excess of doctor-diagnosed asthma, IAF
was not a major factor in doctor-diagnosed asthma or
airway obstruction although women with higher IAF
perceived more severe asthma symptoms which did not
correlate with lower FEV1. Higher IAF was significantly
associated with lower FEV1 and FVC and in men SDB
mechanisms may contribute up to one quarter of this
association.
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